| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
| 08/28/2008 | US20080202684 Wood adhesives containing solid residues of biomass fermentations |
| 08/28/2008 | US20080202541 Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes |
| 08/28/2008 | CA2717664A1 Compositions and methods useful for site-directed recombination in plants |
| 08/28/2008 | CA2679107A1 Process for producing and purifying factor viii and its derivatives |
| 08/28/2008 | CA2678986A1 Erythropoietin fusion protein |
| 08/28/2008 | CA2678941A1 Triazole macrocycle systems |
| 08/28/2008 | CA2678755A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | CA2678669A1 Transglutaminase variants with improved specificity |
| 08/28/2008 | CA2678618A1 Modulation of nkt cell activity with antigen-loaded cd1d molecules |
| 08/28/2008 | CA2678493A1 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 08/28/2008 | CA2677023A1 Method of purification of hydrophobic proteins |
| 08/27/2008 | EP1962096A2 SCD40L, PAPP-A, and placental growth factor (PIGF) as biochemical marker combination for cardiovascular diseases |
| 08/27/2008 | EP1961822A2 Control of fruit dehiscence in arabidopsis by indehiscent1 genes |
| 08/27/2008 | EP1961821A1 Erythropoietin fusion protein |
| 08/27/2008 | EP1961820A2 Lage-1 tumor associated nucleic acids |
| 08/27/2008 | EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer |
| 08/27/2008 | EP1961818A2 Novel fetal genes |
| 08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
| 08/27/2008 | EP1961767A2 Diagnosis and treatment of cancers and other conditions |
| 08/27/2008 | EP1961766A1 Method for the diagnosis of alzheimer's disease |
| 08/27/2008 | EP1961765A1 Truncated PTH peptides with a cyclic conformation |
| 08/27/2008 | EP1961764A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient |
| 08/27/2008 | EP1961763A1 Compounds regulating CRT, KDEL receptor and/or ERp-57 exposure and uses thereof to evaluate the efficiency of a cancer treatment |
| 08/27/2008 | EP1961762A1 Inhibitors of protein phosphatase 1/GADD34, preparation and uses thereof |
| 08/27/2008 | EP1961760A2 Peptides and compounds that bind to a thrombopoietin receptor |
| 08/27/2008 | EP1961427A2 Neisserial vaccine compositions comprising a combination of antigens |
| 08/27/2008 | EP1961425A2 Methods and compositions for the prevention and treatment of anemia |
| 08/27/2008 | EP1961424A1 Activation of peptide prodrugs by HK2 |
| 08/27/2008 | EP1960781A2 Compositions and methods for detecting phosphomonoester |
| 08/27/2008 | EP1960778A2 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors |
| 08/27/2008 | EP1960527A2 Methods for generating antigen-specific effector t cells |
| 08/27/2008 | EP1960523A1 Modified pore-forming protein toxins and use thereof |
| 08/27/2008 | EP1960514A1 Recombinant cell lines for the stable and high-level production of biologically active dkk1 protein |
| 08/27/2008 | EP1960427A1 Multimeric fc receptor polypeptides |
| 08/27/2008 | EP1960426A1 Novel neurotrophic factor protein and uses thereof |
| 08/27/2008 | EP1960425A2 Neurotrophin-derived peptide sequences |
| 08/27/2008 | EP1960424A2 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae |
| 08/27/2008 | EP1960423A2 Synthesis of peptide t-20 using peptide intermediate fragments |
| 08/27/2008 | EP1960422A2 Potent compstatin analogs |
| 08/27/2008 | EP1960419A2 Method for purifying fsh or a fsh mutant |
| 08/27/2008 | EP1959983A2 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 08/27/2008 | EP1959982A1 Methods and compositions for preventing and/or treating pancreatitis |
| 08/27/2008 | EP1697411A4 Process for purifying interferon beta |
| 08/27/2008 | EP1694703A4 Process for purifying interferon beta |
| 08/27/2008 | EP1591518B1 Process for preparing phycoerythrin with high optical density |
| 08/27/2008 | EP1521774B1 Truncated tau proteins |
| 08/27/2008 | EP1456394B1 Methods of using improved polymerases |
| 08/27/2008 | EP1440156B1 Antigens and vectors for vaccination |
| 08/27/2008 | EP1382678B1 Guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same |
| 08/27/2008 | EP1381864B1 Detection of candida |
| 08/27/2008 | EP1355942B1 Glp-1 fusion proteins |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1322665B1 Hiv peptides from conserved regions in gag p17 and their applications, such as vaccines |
| 08/27/2008 | EP1272212B1 Migraine and vasodilation treatment |
| 08/27/2008 | EP1257564B1 Process for purification of recombinant hcg having a specific bioactivity |
| 08/27/2008 | EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/27/2008 | EP1208204B1 Plant reproduction proteins |
| 08/27/2008 | EP1185653B1 Scorpion toxins from buthotus judaicus |
| 08/27/2008 | EP1156817B1 Controlling protein levels in eucaryotic organisms |
| 08/27/2008 | EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1 |
| 08/27/2008 | EP1007555B1 Tropoelastin derivatives |
| 08/27/2008 | EP0931157B1 Retroviral vectors |
| 08/27/2008 | EP0827410B1 Method for introducing and expressing genes in animal cells |
| 08/27/2008 | EP0826060B1 Embedded expression of heterologous proteins |
| 08/27/2008 | CN101253267A Materials and methods for respiratory disease control in canines |
| 08/27/2008 | CN101253266A Gene capable of enhancing low temperature fermentation ability and/or freezing stress resistance and use thereof |
| 08/27/2008 | CN101253264A 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ |
| 08/27/2008 | CN101253196A Cleavage of precursors of insulins by a variant of trypsin |
| 08/27/2008 | CN101253195A Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |
| 08/27/2008 | CN101253194A Growth-stimulating polypeptides for use in fish and crustaceans |
| 08/27/2008 | CN101253193A Modified spider silk proteins |
| 08/27/2008 | CN101250547A Recombinant expression of human desmocyte growth factor-21 |
| 08/27/2008 | CN101250538A Cultivated silkworm microsporidian sporoderm protein SWP32 gene |
| 08/27/2008 | CN101250537A Cultivated silkworm microsporidian sporoderm protein SWP30 gene |
| 08/27/2008 | CN101250536A Cultivated silkworm microsporidian sporoderm protein SWP25 gene |
| 08/27/2008 | CN101250534A Protein coded sequence of cucumber TTG1-like gene |
| 08/27/2008 | CN101250533A Kandelia candel mangrove metallothionein gene and coded sequence thereof |
| 08/27/2008 | CN101250532A Butterfly orchid PhAGCu gene coded sequence and uses thereof |
| 08/27/2008 | CN101250531A Nucleotide sequence, expression vector containing the same, zooblast inverted from said vector and method for producing human fsh using the zooblast |
| 08/27/2008 | CN101250530A Recombinant hirudin coding gene and uses thereof |
| 08/27/2008 | CN101250529A Horse infectious anemia virus soluble acceptor, coded sequence and uses thereof |
| 08/27/2008 | CN101250528A Domestic pig proliferation inducing ligand cDNA as well as clone method and recombinant uses thereof |
| 08/27/2008 | CN101250527A Three-yellow chicken B lymphocyte stimulating factor cDNA as well as clone method and recombinant uses thereof |
| 08/27/2008 | CN101250526A Y gene order of benzene induced aplastic anemia related antigen specific TCR V alpha 19 |
| 08/27/2008 | CN101250525A Method for expressing recombinant human growth hormone and special expression case thereof |
| 08/27/2008 | CN101250519A Prokaryotic expression of soluble interleukins 15 acceptor alpha sub-unit and purifying method |
| 08/27/2008 | CN101250517A Expression of human cardiac muscle type fatty acid binding proteins in bacillus coli DH5 alpha and purification |
| 08/27/2008 | CN101250225A Method for preparing chloromycetin complete antigen |
| 08/27/2008 | CN101250224A Method for high-effective production of pig leucocyte interferon |
| 08/27/2008 | CN101250223A Method for preparing bovine leukocyte interferon |
| 08/27/2008 | CN101250222A Ascidian antibacterial peptide, precursor peptide, coding gene and use thereof |
| 08/27/2008 | CN101250221A Plant ABA signal transduction regulatory protein as well as coding gene and use thereof |
| 08/27/2008 | CN101250220A Vegetable stress-resistant related protein as well as coding gene and application thereof |
| 08/27/2008 | CN101249258A An uro-genital condition treatment system |
| 08/27/2008 | CN100413970C Hepatitis B surface antigen blending gene and protein for carboxyl terminal containing precursor S2 immune decision cluster |
| 08/27/2008 | CN100413966C Delta-endotoxin genes and methods for their use |
| 08/27/2008 | CN100413888C Soluble polypeptides |
| 08/27/2008 | CN100413887C P53 negative controllable molecule and genes encoding same |
| 08/27/2008 | CN100413886C Protein associated to pig immunity and growth trait, coding genes and application |